Stamford, CT -- (SBWIRE) -- 01/20/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: American Express Company (NYSE:AXP), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ARMOUR Residential REIT, Inc. (NYSE:ARR), Gilead Sciences, Inc. (NASDAQ:GILD)
American Express Company (NYSE:AXP) opened the session at $91.83, trading in a range of $90.55 - $93.62. The stock showed a positive performance of +3.63% in the last trading session from its previous close of $87.78 and closed at $90.97. The stock traded on a volume of 15.01 million shares and the average volume of the stock remained 3.88 million shares. American Express Company (American Express) is a global service company. The Company’s range of products and services includes Charge and credit card products, Expense management products and services, Consumer and business travel services, Stored value products, such as travelers cheques and other prepaid products, Network services, merchant acquisition and processing, servicing and settlement, and point-of-sale, marketing and information products and services for merchants, and fee services, including market and trend analyses and related consulting services, fraud prevention services, and the design of customized customer loyalty and rewards programs.
For How Long AXP will Fight for Profitability? Read This Trend Analysis report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded 12.24 million shares in the last business day while the average volume of the stock remained 5.27 million shares. The stock showed a negative movement of -5.96% to end at $7.26. The 52 week range of the stock remained $4.05 - $10.30. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Has ARNA Found The Bottom And Ready To Gain Momentum? Find Out Here
ARMOUR Residential REIT, Inc. (NYSE:ARR) reported 12.83 million shares were exchanged during the last trade, while the average volume is about 6.21 million shares. The stock dropped -0.49% and finished the day at $4.04. The beta of the stock is recorded at 0.67. ARMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc. The Company invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities (RMBS).
Why Should Investors Buy ARR After the Recent Fall? Just Go Here and Find Out
Gilead Sciences, Inc. (NASDAQ:GILD) shares rose, +0.64 percent from its previous close of $77.90 to close at $78.40. Traded with volume of 11.86 million shares in the prior session and the average volume of the stock remained 10.98 million shares. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions. The Company has operations in North America, Europe and Asia Pacific.
Why Should Investors Buy GILD After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)